A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples